Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
06/13/2012 | CN1835976B Aglycosyl anti- CD154 (CD 40 ligand) antibodies and uses thereof |
06/13/2012 | CN102498101A Aniline compounds |
06/13/2012 | CN102498091A Glycine compound |
06/13/2012 | CN102497868A Mixture of non-digestible oligosaccharides for stimulating the immune system |
06/13/2012 | CN102492594A Bamboo juice wine and preparation method thereof |
06/13/2012 | CN102492038A Anti-human Tim-3 neutralized monoclonal antibody L3D and application thereof |
06/13/2012 | CN102491972A Carbazole derivative, preparation method thereof, and application of carbazole derivative serving as anticancer drug |
06/13/2012 | CN102488882A Compound propolis composition for treating porcine respiratory disease syndrome and preparation method thereof |
06/13/2012 | CN102488880A Human body massage liquid prepared from ginger essential oil, preparation method thereof, and massage liquid supplying apparatus |
06/13/2012 | CN102488877A Traditional Chinese medicine composition for treating lung heat |
06/13/2012 | CN102488857A Chinese herbal preparation capable of diffusing lung, reducing phlegm and relieving cough |
06/13/2012 | CN102488834A Medicament for treating acute upper respiratory tract infection |
06/13/2012 | CN102488833A Traditional Chinese medicine preparation possessing efficacy of dispelling wind, ventilating lung, eliminating heat and relieving cough |
06/13/2012 | CN102488831A Medicine for treating respiratory diseases and preparation method thereof |
06/13/2012 | CN102488828A Chinese medicinal composition for treating infectious bronchitis and its preparation method |
06/13/2012 | CN102488816A Chinese patent drug for insufficiency of kidney-yang |
06/13/2012 | CN102488807A Medicine for treating asthma |
06/13/2012 | CN102488803A Preparation method for superfine bupleurum powder under normal temperature and special bidirectional airflow sieving machine |
06/13/2012 | CN102488796A Multifunctional essential oil for ear, nose and eye and preparation method thereof |
06/13/2012 | CN102488792A Traditional Chinese medicinal composition for treating rhinitis and paranasal sinusitis and preparation method thereof |
06/13/2012 | CN102488788A Medicinal composition for treating asthma in children |
06/13/2012 | CN102488778A Chinese traditional medicine preparation for treating upper respiratory tract infection of livestock and preparation method thereof |
06/13/2012 | CN102488766A Chinese medicinal effective fraction composition for treating cough and preparation method thereof |
06/13/2012 | CN102488758A Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof |
06/13/2012 | CN102488750A Xiasangju capsule and its preparation method |
06/13/2012 | CN102488746A Compound propolis composition for treating swine infectious atrophic rhinitis and preparation method thereof |
06/13/2012 | CN102488712A Artificial bezoar inclusion compound, its preparation method and application |
06/13/2012 | CN102488711A Method for preparing compound paracetamol and amantadine hydrochloride tablet |
06/13/2012 | CN102488699A Application of paeoniflorin in preparation of medicine for preventing and curing pulmonary fibrosis |
06/13/2012 | CN102488695A Instant florfenicol and preparation method thereof |
06/13/2012 | CN102488672A Transdermal drug delivery system of hydrosol |
06/13/2012 | CN102488660A Sustained-release pellet containing pirfeudone |
06/13/2012 | CN102488614A Massage health-care ball |
06/13/2012 | CN102138996B Honey pomelo peel processing powder |
06/13/2012 | CN102028678B Application of salvianolic acid A in preparing anti-tumor metastasis medicine |
06/13/2012 | CN102008667B Preparation method for traditional Chinese medicine composition with antibacterium and antiphlogosis efficacies |
06/13/2012 | CN101810844B External plaster for preventing disease and manufacturing method thereof |
06/13/2012 | CN101721363B Cefixime oral administration mixed suspension and preparation method thereof |
06/13/2012 | CN101636397B Urea compounds, preparation methods and pharmaceutical uses thereof |
06/13/2012 | CN101474260B Shuang Huanglian liquid preparation and method for measuring content thereof |
06/13/2012 | CN101389221B Silver/water, silver gels and silver-based compositions, method for fabricating and using the same |
06/13/2012 | CN101306173B Decoction for treating chronic simple rhinitis |
06/12/2012 | US8198483 Phenethanolamine derivatives for treatment of respiratory diseases |
06/12/2012 | US8198295 Benzonaphthyridines |
06/12/2012 | US8198288 Tetrahydropyrrolopyrimidinediones and their use in therapy |
06/12/2012 | US8198286 Sodium channel blockers |
06/12/2012 | US8197814 Method for treating the Th2-mediated disease |
06/12/2012 | US8197813 Human antibodies that bind human TNFα |
06/12/2012 | CA2512198C Development of an anti-cough, anti-tussive and throat soothing herbal formulation |
06/07/2012 | WO2012075115A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2 |
06/07/2012 | WO2012074926A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | WO2012074231A2 Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration |
06/07/2012 | WO2012073856A1 Oil-in-water emulsion composition containing difluprednate and tobramycin |
06/07/2012 | WO2012073025A1 Glucosaminoglucans such as heparin for use in the treatment of pulmonary inflammation such as copd |
06/07/2012 | WO2012072727A1 Crystalline modification of n-(3,5-dichloropyridin-4-yl)-[1-(4 -fluorobenzyl)-7-azaindol-3-yl)]glyoxylic acid amide as inhibitor of pde4 |
06/07/2012 | WO2012051339A3 Methods and compositions for treating respiratory conditions using platelet enriched plasma |
06/07/2012 | WO2012019178A9 Methods of treating and diagnosing acute chest syndrome |
06/07/2012 | US20120142766 Substituted 1,3-dioxanes and their uses |
06/07/2012 | US20120142757 RNAi Modulation of AHA and Therapeutic Uses Thereof |
06/07/2012 | US20120142745 Novel phenyl oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
06/07/2012 | US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142739 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142736 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142735 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]- 1h-indol-3-yl]-methanones |
06/07/2012 | US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2 |
06/07/2012 | US20120142726 Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
06/07/2012 | US20120142716 4-pyrimidinesulfamide derivative |
06/07/2012 | US20120142715 Polymorph of [4,6-bis(dimethylamino)-2-(4-benzyl)pyrimidin-5-yl] |
06/07/2012 | US20120142692 Antifolate combinations |
06/07/2012 | US20120142688 Preparation of 1-(substituted aryl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications |
06/07/2012 | US20120142687 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity |
06/07/2012 | US20120142683 Pyrimidine substituted purine compounds as kinase (s) inhibitors |
06/07/2012 | US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor |
06/07/2012 | US20120142671 Benzamides and nicotinamides as syk modulators |
06/07/2012 | US20120142668 Cathepsin c inhibitors |
06/07/2012 | US20120142666 Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor |
06/07/2012 | US20120142664 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142663 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142662 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142661 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142659 Compounds and their use as ikach blockers |
06/07/2012 | US20120142651 Method of treatment of allergic rhinitis |
06/07/2012 | US20120142650 Method for treating lung disease |
06/07/2012 | US20120142647 Novel Compounds as Respiratory Stimulants for Treatment of Breathing Control Disorders or Diseases |
06/07/2012 | US20120142646 Novel Compounds 621 |
06/07/2012 | US20120142642 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142640 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators |
06/07/2012 | US20120142639 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142633 Methylpyrrolopyridinecarboxamides |
06/07/2012 | US20120142620 Core 2 glcnac-t inhibitors |
06/07/2012 | US20120142619 Medicinal carbohydrates for treatment of respiratory conditions |
06/07/2012 | US20120142614 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis |
06/07/2012 | US20120142595 Tissue protective peptides and uses thereof |
06/07/2012 | US20120141549 Oligonucleotides targeting asthma inflammation processes |
06/07/2012 | US20120141541 Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages |
06/07/2012 | US20120141532 Botulinum Toxin Formulation |
06/07/2012 | US20120141514 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
06/07/2012 | US20120141492 Anti-il 17a /il-17f cross-reactive antibodies and methods of use thereof |
06/07/2012 | US20120141489 Hypoxia Induced Mitogenic Factor |